AdvanTX is a new initiative offering centralized resource support for development of therapeutic related research projects.
The Office of the Vice Chancellor for Research (OVCR) has launched AdvanTx: The UNC Advanced Therapeutics Initiative, a centralized resource to support development of therapeutic-related research and commercialization projects. The initiative aims to serve faculty in advancing therapeutic projects through scientific guidance, coordination of university and external resources, and development of a commercial strategy.
Research investigators are highly encouraged to contribute their therapeutic target(s) or gene concepts, discoveries, or ongoing programs – independent of the stage of development – by completing a brief one-page questionnaire which can be accessed via the website.
After the project information is submitted, those with a high priority-rating will be promptly contacted by members of the AdvanTx team, a pan-campus group of therapeutics and innovation translation experts. If selected for support, the team will work closely with the researcher to support advancement of the therapeutic project.
Information on the initiative, along with submission instructions, can be found on the OVCR’s AdvanTX: UNC Advance Therapeutics Initiative portal.